- Alzheimer disease
- Charcot-Marie-Tooth disease
- Epilepsy
- Forearm pain
- Gait abnormality
- Guillain-Barre syndrome
- Headache
- Memory disorder
- Mild cognitive impairment
- Movement disorder
- Multiple sclerosis
- Myasthenia gravis
- Nerve pain
- Neurological disorder
- Peripheral neuropathy
- Primary progressive aphasia (PPA)
- Stroke
- Transient ischemic attack
- Traumatic brain injury
David R. Lynch, MD, PhD
About me
- Professor of Neurology
- Professor of Neurology in Pediatrics
My education and training
- Medical School: Johns Hopkins University School of Medicine
- Residency: University of Pennsylvania Health System
- Fellowship: University of Pennsylvania Health System
Spoken languages
Insurance accepted
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
- Devoted Health Choice Giveback Pennsylvania (PPO)
- Devoted Health Choice Pennsylvania (PPO)
- Devoted Health Choice Plus Pennsylvania (PPO)
- Devoted Health Core Pennsylvania (HMO)
- Devoted Health Dual Plus Pennsylvania (HMO D-SNP)
- Devoted Health Giveback Pennsylvania (HMO)
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Qualifications and experience
- Neurology, 1993
- American Academy of Neurology, National
- American Neurological Association, International
- Australian Medical Research Council, International
- Cooperative Ataxia Group (CAG), National
- French Government Scientific Review, International
- Friedreich Ataxia Research Alliance, National
- Government, Czech Republic, International
- MDA, National
- National Ataxia Foundation, National
- NIH, National
- NIH RAID Program, National
- NINDS Committee on Common Data Elements, International
- Society for Neuroscience, National
Treatments and conditions
Research
Publications
Morgan C Devore 1, Christina Lam 2, Emily Xiao 2, Jeremy Devore 2, Kassandra R C McCain 2, Graham Wiley 3, Courtney C Park 4, David R Lynch 4, Sanjay I Bidichandani FXN protomutations are the source of pathogenic expanded GAA alleles in Friedreich ataxia and explain its unequal population distribution , Hum Mol Genet , 35(11): 2026 ,ddag046.
Ali SAH, Early J, Farmer JM, Gelbard S, Corben L, Rance G, Lynch DR. Listening in Spatialized Noise-Sentences (LiSN-S) as a Measure of Auditory Function in Friedreich Ataxia. , Cerebellum, 25(3): 2026,60
Satoshi Miyashita, Anthony Zaki, Kaitlin Schlabach, Gabriel Kim, Juliane K. Vierecke, David Lynch, Carmela Tan, Eileen Hsich, Paulino Alvarez Advanced Heart Failure in Friedreich's Ataxia: A Story of Challenges, Opportunities, and Hope , JACC: Case Reports, 31(17): 2026,107391.
Gaetz W, Saleh MG, Birnbaum C, Bloy L, Roberts TPL, Lynch DR. Myo-inositol elevation as an in vivo marker of reactive gliosis in pediatric Friedreich ataxia: evidence from HERMES-edited MR spectroscopy , Neuroimage: Clinical, 50:: 2026,103983.
Devore, M, Lam, C, Wiley, C, Park, CC, Lynch, DR, Bidichandani, S Unrecognized high prevalence of expanded composite repeats in Friedreich ataxia , Hum Mol Gen, 35(3): 2026,:ddaf190.
Lazaropolous, MP, Devore, M, Bidichandani, SJ, LynchD.R. Compound Heterozygote Friedreich Ataxia Patients With Covert Proximal FXN Gene Deletion , Annals of Clinical and Translational Neurology: 2026
Gitman, a., Bhandari, N., Castellano, M, Schadt, K., Cancio, M, Lynch, D. R. Stem cell transplantation in Friedreich ataxia: Cure for Leukemia but no effect on neurological progression , Annals Clinical and Translational Neurol: 2026
Rummey C, Thomas-Black G, Garcia-Moreno H, Lynch DR, Abeti R, Arisoy H, Heslegrave A, Zetterberg H, Giunti P; European Friedreich's Ataxia Consortium for Translational Studies (EFACTS). Increase of Plasma Biomarkers in Friedreich's Ataxia: Potential Insights into Disease Pathology , Movement disorders, 409: 2025,1863-1873.
David R. Lynch, Angie Goldsberry, Christian Rummey, Jennifer Farmer, Sylvia Boesch, Martin B. Delatycki, Paola Giunti, J. Chad Hoyle, Caterina Mariotti, Katherine D. Mathews, Wolfgang Nachbauer, Susan Perlman, Sub H. Subramony, George Wilmot, Theresa Zesiewicz, Lisa Weissfeld & Colin Meyer Propensity-matched analysis comparing omaveloxolone treatment to Friedreich ataxia natural history data: a plain language summary , Future Neurology: 2025
Shiraishi DH, Saha S, Adanyeguh IM, Cocozza S, Corben LA, Deistung A, Delatycki MB, Dogan I, Gaetz W, Georgiou-Karistianis N, Graf S, Grisoli M, Henry PG, Jarola GM, Joers JM, Langkammer C, Lenglet C, Li J, Lobo CC, Lock EF, Lynch DR, Mareci TH, Martinez ARM, Monti S, Nigri A, Pandolfo M, Reetz K, Roberts TP, Romanzetti S, Rudko DA, Scaravilli A, Schulz JB, Subramony SH, Timmann D, França MC Jr, Harding IH, Rezende TJR; TRACK-FA Neuroimaging Consortium. Automated Deep Learning-based Segmentation of the Dentate Nucleus Using Quantitative Susceptibility Mapping MRI , Radiol Artif Intell .: 2025,e240478.